Unibest
← Back to patent-cliff list

Iodixanol

Tier C — Watch / trade

Iodixanol

Ge Healthcare
Originator
1996
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type

Targets:Not applicable

Brand:OptiPrep, Acupaque, Visipaque

Indications (approved):Contrast imaging, Cardiovascular contrast agent

Regional status

US
Approved
1996-03-22
EU
-
China
Approved
2001-08-22
Japan
-

Synthetic routes & intermediates

Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.

Frequently asked questions

What are the approved indications of Iodixanol?

Approved indications include: Contrast imaging, Cardiovascular contrast agent.

When does the Iodixanol patent expire?

No public expiry year is available for Iodixanol yet; this page updates once verified.

How do I get a quote for Iodixanol intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-10-04